000520 — Samil Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Market Cap
KR₩264bn
Enterprise Value
KR₩409bn
Revenue
KR₩220bn

Annual balance sheet for Samil Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	17,214	15,261	1,966	929	5,141
Net Total Accounts Receivable
Net Total Receivables	30,195	31,374	34,304	35,900	35,779
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	72,523	76,711	74,781	81,115	91,346
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	64,808	103,394	233,946	242,198	252,893
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	191,661	226,405	356,700	370,680	395,071
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	98,684	121,674	132,592	168,675	106,660
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	128,110	160,658	230,881	242,853	218,947
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	63,551	65,746	125,820	127,827	176,124
Total Liabilities & Shareholders' Equity	191,661	226,405	356,700	370,680	395,071
Total Common Shares Outstanding